FY 2014 federal appropriations omnibus legislation restores $85 million in industry-provided user fees

Posted on Mon/20/JanuaryMon/20/January by AZBio

FY 2014 appropriations omnibus legislation to restore $85 million in industry-provided user fees that were lost to FDA in FY 2013 due to the sequester.Continue reading→

Medtronic CoreValve® System Obtains Early FDA Approval on Exceptional Clinical Performance

Posted on Mon/20/JanuaryMon/20/January by AZBio

Self-Expanding Aortic Valve Serves Broad Spectrum of Potential Transcatheter Aortic Valve Replacement (TAVR) Patients Who Are Unable to Undergo SurgeryContinue reading→

Telestroke is cost-saving for society Mayo Clinic researchers show

Posted on Sun/19/JanuarySun/19/January by AZBio

PHOENIX — Jan. 16, 2014 — Researchers have found that using telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for society. The research was recently published in the American Journal of Managed Care.Continue reading→

Matt McGuire to lead Cancer Treatment Centers’ Arizona facility

Posted on Thu/16/JanuaryThu/16/January by AZBio

Matt McGuire, who was serving as interim president and CEO for Cancer Treatment Centers of America at Western Regional Medical Center, has been selected for the position on a permanent basis.Continue reading→

Castle Biosciences Announces Data Demonstrating Ability to Identify Esophageal Cancer Patients Resistant to Standard Pre-Surgical Treatment of Chemotherapy and Radiation

Posted on Thu/16/JanuaryThu/16/January by AZBio

Enables physicians and patients to proactively avoid toxicities from treatments unlikely to provide benefit. Data presented at ASCO’s 2014 Gastrointestinal Cancers SymposiumContinue reading→

University of Arizona Senior Earns SynCardia’s 1st Annual Anna Salazar Memorial Engineering Scholarship Award Honors Late Senior Quality Engineer Anna Salazar and Helps Female Engineering Students Further Their Education

Posted on Wed/15/JanuaryWed/15/January by AZBio

A University of Arizona senior whose aim is to develop medical devices that monitor heart health is the first recipient of the Anna Salazar Memorial Engineering Scholarship presented by SynCardia Systems, Inc.Continue reading→

Insys Announces Details of Product Development Pipeline

Posted on Tue/14/JanuarySun/19/January by AZBio

PHOENIX, AZ–(Marketwired – Jan 13, 2014) – Insys Therapeutics, Inc. (NASDAQ: INSY) today unveiled details of its portfolio pipeline, focused on innovative supportive care and therapy products. The Company intends to file one New Drug Application (NDA) and at least three Investigational New Drug (IND) applications with the Food and Drug Administration (FDA) in 2014.Continue reading→